Kevin Ali
Also at Organon & Co
About
Kevin Ali is a seasoned leader in the pharmaceutical industry with over three decades of experience in healthcare commercialization and strategic management. He began his notable career at Merck & Co., Inc., where he held progressive roles including Managing Director in Turkey and Germany, Senior Vice President in various capacity, as well as leading the Emerging Markets and International Business divisions. His leadership in these diverse roles laid the groundwork for his future contributions to the healthcare sector.
In 2021, he took on the role of Chief Executive Officer at OGN, a company founded with a mission to improve women's health globally. His vision and strategic approach have been instrumental in shaping the company from its inception, where he was key in designing the organizational structure and selecting the senior leadership team.
Beyond his executive responsibilities, his professional journey reflects a commitment to innovative approaches in global healthcare markets. His extensive background from his days at Merck to his current role underscores the integration of international experience with a focus on transformative healthcare solutions.
$OGN Performance Under Kevin Ali
Past Roles
Fixed Compensation
Performance Compensation
Annual Incentive Plan (AIP)
Performance Stock Units (PSUs)
Equity Incentive Plan Awards
This detailed structure aligns the performance compensation components with the company’s strategic financial goals and performance indicators.